Longaeva Partners L.P.
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Longaeva Partners L.P. reported 20 stock positions worth $163.6 million. Its top holding was Schwab (charles) (SCHW) at 26.8% of the portfolio, followed by Entergy (ETR, 10.4%) and American Electric Power (AEP, 10.0%).
- Most Recent 13F
- Q2 2026
- Location
- Chicago, IL
- CIK
- 0002054122
- Portfolio Value
- $163.6M (Q1 2025)
- SEC Filing
- 0000950123-25-005605 ↗ filed May 15, 2025
Holdings Value
Holdings 20 stocks · $163.6M
| SCHW Schwab (charles) Corp. | 26.76% | 559,300 | $43.8M | — |
| ETR Entergy Corp. | 10.45% | 200,000 | $17.1M | — |
| AEP American Electric Power | 10.02% | 150,000 | $16.4M | — |
| SARO Standardaero Inc. | 9.36% | 575,000 | $15.3M | — |
| VIK Viking Holdings Ltd. | 7.38% | 303,723 | $12.1M | — |
| WAY Waystar Holding Corp. | 7.18% | 314,300 | $11.7M | — |
| ADT Adt Inc. | 6.10% | 1,225,151 | $10.0M | — |
| SFD Smithfield Foods Inc. | 5.25% | 420,915 | $8.6M | — |
| SAIL Sailpoint Inc. | 4.01% | 350,365 | $6.6M | — |
| VG Venture Global Inc. Class A | 3.54% | 561,695 | $5.8M | — |
| BBNX Beta Bionics Inc. | 2.06% | 275,825 | $3.4M | — |
| RACE Ferrari NV | 1.97% | 7,534 | $3.2M | — |
| PRMB Primo Brands Corp. | 1.65% | 76,281 | $2.7M | — |
| BTSG Brightspring Health Services | 1.11% | 99,973 | $1.8M | — |
| NPCE Neuropace Inc. | 0.75% | 99,985 | $1.2M | — |
| BNTC Benitec Biopharma Inc. | 0.64% | 80,000 | $1.0M | — |
| AKBA Akebia Therapeutics Inc. | 0.59% | 500,000 | $960K | — |
| KRMN Karman Holdings Inc. | 0.51% | 25,000 | $836K | — |
| TTAM Titan America SA | 0.50% | 60,000 | $811K | — |
| KMTS Kestra Medical Technologies | 0.19% | 12,600 | $314K | — |
Other holdings (1): bonds, preferreds, convertibles and warrants · $13.0M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| KKR & CO INC (KKR 6.25 03/01/28 D) | 6.25 CON SER D | 262,500 | $13.0M | — |
Total filed on the 13F, all lines: $176.6M.
Portfolio Sells Q1 2025
No earlier filing to compare with.
Portfolio Buys Q1 2025
No earlier filing to compare with.